WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia

Leukemia

Volumn 13, Issue 6, 1999, Pages 891-900

  Patmasiriwat, P ^a,b   Fraizer, G ^a   Kantarjian, H ^a   Saunders, G F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

ALL; AML; GATA; MDS; WT1

Indexed keywords

BETA ACTIN; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 1; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032971182     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401414     Document Type: Article

References (54)

1. Gilbert SF. Developmental Biology, 3rd edn. Sinauer: Sunderland, MA, 1991, pp 582-586.
2. Beckwith JB, Tisher CC, Brenner BM (eds). Renal Pathology, vol 2. JB Lippincott: Philadelphia, 1989, pp 1433-1466.
3. Riccardi VM, Sujansky E, Smith AC, Francke U. Chromosomal imbalance in the Aniridia-Wilms tumor association: 11p interstitial deletion. Pediatrics 1978; 61: 604-610.
4. Kaneko Y, Eques MC, Rowley JD. Interstitial deletion of short arm of chromosome 11 limited to Wilms tumor cells in a patient without aniridia. Cancer Res 1981; 41: 4577-4578.
5. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ III. Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science 1991; 253: 1550-1553.
6. Rauscher FJ III, Morris JF, Tournay OE, Cook DM, Curran T. Binding of the Wilms tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 1990; 250: 1259-1262.
7. Bickmore WA, Oghene K, Little MH, Seawright A, van Heyningen V, Hastie ND. Modulation of DNA binding specificity by alternative splicing of the Wilms' tumor wt1 gene transcript. Science 1992; 257: 235-237.
8. Fraizer GC, Wu YJ, Hewitt SM, Maity T, Ton CC, Huff V, Saunders GF. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter. J Biol Chem 1994; 269: 8892-8900.
9. Hewitt SM, Fraizer GC, Saunders GF. Transcriptional silencer of the Wilms' tumor gene WT1 contains an alu repeat. J Biol Chem 1995; 270: 17908-17912.
10. Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ III, Saunders GF. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res 1995; 55: 5386-5389.
11. Dey BR, Sukhatme VP, Robert AB, Sporn MB, Rauscher FJ III, Kim SJ. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol 1994; 8: 595-602.
12. Goodyer P, Dehdi M, Torban E, Bruening W, Pelletier J. Repression of the retinoic acid receptor-alpha gene by Wilms' tumor suppressor gene product, wt1. Oncogene 1995; 10: 1125-1129.
13. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Robert D, Fletcher J, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Hausman DE, Haber DA. The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat Genet 1993; 4: 415-420.
14. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol 1991; 11: 1707-1712.
15. Fraizer GC, Patmasiriwat P, Zhang X, Saunders GF. Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow. Blood 1995; 86: 4704-4706.
16. Miwa H, Beran M, Saunders GF. Expression of Wilms' tumor gene (WT1) in human leukemia. Leukemia 1992; 6: 405-409.
17. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I. Expression of the candidate Wilms' tumor gene, WT1, in human leukemia cells. Leukemia 1993; 7: 970-977.
18. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 1994; 84: 3071-3079.
19. Wu Y, Fraizer GC, Saunders GF. GATA-1 transactivates the WT1 hematopoietic specific enhancer. J Biol Chem 1995; 270: 5944-5949.
20. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992; 80: 575-581.
21. Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH, Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991; 349: 257-260.
22. Zhang X, Xing G, Fraizer GC, Saunders GF. Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb. J Biol Chem 1997; 272: 29272-29280.
23. Patmasiriwat P, Fraizer GC, Claxton D, Kantarjian H, Saunders GF. Expression pattern of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities. Leukemia 1996; 10: 1127-1133.
24. Pevny L, Lin CS, D'Agati V, Simon MC, Orkin SH, Costantini F. Development of hematopoietic cells lacking transcription factor GATA-1. Development 1995; 121: 163-172.
25. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH. An early hematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994; 371: 221-226.
26. Simon MC, Pevny L, Wiles MV, Keller G, Costantini F, Orkin SH. Rescue of erythroid development in gene targeted GATA-1-mouse embryonic stem cells. Nat Genet 1992; 1: 92-98.
27. Evans T, Reitman M, Felsenfeld G. An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common in all chicken globin genes. Proc Natl Acad Sci USA 1988; 85: 5976-5980.
28. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
29. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukemias. French-American-British (FAB) Co-operative Group. Br J Haematol 1976; 33: 451-458.
30. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemias. A report of the French-American-British Co-operative Group. Ann Intern Med 1985; 103: 620-625.
31. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlations. Br J Haematol 1981; 47: 553-561.
32. First MIC Cooperative Study Group. Morphologic, immunologic and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Cancer Genet Cytogenet 1986; 23: 189-197.
33. Second MIC Cooperative Study Group. Morphologic, immunologic and cytogenetic (MIC) working classification of acute myeloid leukemias. Br J Haematol 1988; 68: 487-494.
34. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
35. Barch MJ (ed). The ACT Cytogenetics Laboratory Manual, 2nd edn. Raven Press: New York, 1991.
36. Mitelman F (ed). Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Karger: Basel, 1991, pp 1-54.
37. Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L. The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 1994; 8: 2138-2143.
38. Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Tbiel E, Presence of Wilms' tumor gene (WT1) transcripts and trie WT1 nuclear protein in the majority of human acute leukemias. Leukemia 1995; 9: 1060-1067.
39. Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Dieter H. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997; 90: 1217-1225.
40. + progenitors. Blood 1997; 90: 4230-4232.
41. Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T, Sugiyama H. Aberrant overexpression of the Wilms' tumor gene (WT1) in human leukemia. Blood 1997; 89: 1405-1412.
42. + progenitors and dowrregulated early in the course of differentiation in vitro. Exp Hematol 1997; 25: 945-950.
43. Phelan SA, Lindberg C, Call KM. Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ 1994; 5: 677-686.
44. Sekiya M, Adachi M, Hinoda Y, Imai K, Yachi A. Downregulation of Wilms' tumor gene (WT1) during myelomonocytic differentiation in HL-60 cells. Blood 1994; 83: 1876-1882.
45. Inoue K, Ogawa H, Yamagami T, Soma T, Tani Y, Tatekawa T, Oji Y, Tamaki H, Kyo T, Dohy H, Hiraoka A, Masaoka T, Kishimoto T, Sugiyama H. Longterm follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 1996; 88: 2267-2278.
46. Shimamoto T, Ohyashiki K, Ohyashiki JH, Kawakubo K, Fujimura T, Iwama H, Nakazawa S, Toyama K. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 1995; 86: 3173-3180.
47. Fraizer GC, Shimamura R, Zhang X, Saunders GF. PAX8 regulates human Wilms' tumor gene transcription through a novel DNA binding site. J Biol Chem 1997; 272: 30678-30687.
48. Smith SI, Weil D, Johnson GR, Boyd AW, Li CL. Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells. Blood 1998; 91: 764-773.
49. Hewitt SM, Fraizer GC, Wu YJ, Rauscher FJ III, Saunders GF. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation. J Biol Chem 1996; 271: 8588-8592.
50. Poleev A, Fickenscher H, Mundlos S, Winterpacht A, Zabel B, Fidler A, Gruss P, Plachov D. PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development 1992; 116: 611-623.
51. Plachov D, Chowdhury K, Whalther C, Simon D, Guenet JL, Gruss P. PAX8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development 1990; 110: 643-651.
52. Harrington MA, Konicek B, Song A, Xia ZL, Fredricks WJ, Rauscher FJ III. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J Biol Chem 1993; 268: 21271-21275.
53. Karakas T, Meithing CC, Maurer U, Weidmann E, Hoelzer D, Bergmann L. The coexpression of bcl-2 and wt1 as a new prognostic factor in acute myeloid leukemia. Proc Am Assoc Cancer Res 1998; 39: 52 (Abstr. 355).
54. Shimamura R, Fraizer GC, Trapman J, Lau Y-FC. Regulation of the genes involved in sex determination and differentiation: SRY, Mullerian inhibiting substance, and androgen receptor by the Wilms' tumor gene WT1. Clin Cancer Res 1998; 3: 2571-2580.